Elizabeth PRODROMOU

Elizabeth PRODROMOU

General Manager, Bristol Myers Squibb Greece

Elizabeth Prodromou has been General Manager at Bristol Myers Squibb Greece since 2017, having pursued a long journey since 2008 in various critical positions within the company, as Regulatory Sciences Director, Market Access Director and Business Unit Director in Oncology and Hematology.

In recent years, BMS has performed a dynamic growth trajectory in Greece, with an innovative portfolio to address unmet medical needs in immuno-oncology, β-thalassemia, multiple sclerosis, psoriasis and idiopathic inflammatory bowel diseases, after Celgene takeover. However, our vision is not limited to the research and development of innovative medicines, but exceeds to the emergence of BMS as a role model of corporate responsibility that is actively involved in public discourse about the NHS sustainability, serves a culture of diversity and inclusion and provides its employees with unique career opportunities.

Lisa is a graduate of the Chemistry Department of the University of Athens, holds a specialization in Strategic Leadership and Business Administration from Columbia Business School and the Global Executive Education Club and started her career in pharmaceutical sector working for Pharmathen, Unipharma and Abbott.